ACADEMIC AND INDUSTRY PERSPECTIVES ON PHARMACOGENOMICS: DRUG OPTIMIZATION

被引：0
|
作者：
Shuldiner, Alan
机构：
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2019年 / 34卷 / 01期
关键词：
D O I：
10.1016/j.dmpk.2018.09.030
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
S8
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [1] Perspectives on the Current State of Pharmacogenomics in Drug Development
    Tamaoki, Mieko
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2009, 129 (01): : 135 - 145
  • [2] Payer perspectives on pharmacogenomics testing and drug development
    Epstein, Robert S.
    Frueh, Felix W.
    Geren, Dawn
    Hummer, Doris
    McKibbin, Scott
    O'Connor, Susan
    Randhawa, Gurvaneet
    Zelman, Benjamin
    PHARMACOGENOMICS, 2009, 10 (01) : 149 - 151
  • [3] Pharmacogenomics of adverse drug reactions: practical applications and perspectives
    Becquemont, Laurent
    PHARMACOGENOMICS, 2009, 10 (06) : 961 - 969
  • [4] Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives
    Mou-Ze Liu
    Hai-Yan He
    Jian-Quan Luo
    Fa-Zhong He
    Zhang-Ren Chen
    Yi-Ping Liu
    Da-Xiong Xiang
    Hong-Hao Zhou
    Wei Zhang
    Archives of Pharmacal Research, 2018, 41 : 725 - 736
  • [5] Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives
    Liu, Mou-Ze
    He, Hai-Yan
    Luo, Jian-Quan
    He, Fa-Zhong
    Chen, Zhang-Ren
    Liu, Yi-Ping
    Xiang, Da-Xiong
    Zhou, Hong-Hao
    Zhang, Wei
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (07) : 725 - 736
  • [6] Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group
    C M Bromley
    S Close
    N Cohen
    R Favis
    B Fijal
    F Gheyas
    W Liu
    C Lopez-Correa
    A Prokop
    J B Singer
    A Snapir
    A Tchelet
    D Wang
    D Goldstaub
    The Pharmacogenomics Journal, 2009, 9 : 14 - 22
  • [7] Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group
    Bromley, C. M.
    Close, S.
    Cohen, N.
    Favis, R.
    Fijal, B.
    Gheyas, F.
    Liu, W.
    Lopez-Correa, C.
    Prokop, A.
    Singer, J. B.
    Snapir, A.
    Tchelet, A.
    Wang, D.
    Goldstaub, D.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (01): : 14 - 22
  • [8] Academic perspectives on the United States food and drug administration's guidance for industry on diabetes mellitus
    Hennekens, Charles H.
    Hebert, Patricia R.
    Schneider, Wendy R.
    O'Brien, Peter
    DeMets, David
    Borer, Jeffrey S.
    CONTEMPORARY CLINICAL TRIALS, 2010, 31 (05) : 411 - 413
  • [9] ACADEMIC-DRUG INDUSTRY FELLOWSHIPS
    PLEASANTS, DZ
    POWELL, JR
    JOHNSTON, JA
    ECKEL, FM
    CLOUTIER, G
    CATO, AE
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1987, 21 (01): : 112 - 114
  • [10] Role of Pharmacogenomics in Antiepileptic Drug Therapy: Current Status and Future Perspectives
    Gambardella, Antonio
    Labate, Angelo
    Mumoli, Laura
    Lopes-Cendes, Iscia
    Cendes, Fernando
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (37) : 5760 - 5765
12345